To include your compound in the COVID-19 Resource Center, submit it here.

Evolus prices $60M IPO

Medical aesthetics company Evolus Inc. (NASDAQ:EOLS) raised $60 million on Feb. 8

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE